NCT03870165

Brief Summary

In a crossover design 10 young healthy adults (20-35 y) will receive stable isotope tracer infusions and perform a single bout of resistance exercise. Immediately after exercise participants will ingest either 3.5 oz of Salmon fillet or its constituent macronutrients as isolated amino acids and fat. Repeated blood and breath samples as well as muscle biopsies will be collected to determine whole body amino acid kinetics, muscle amino acid transporters, anabolic signalling and myofibrillar protein synthesis rates during the trials

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 8, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 11, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 22, 2019

Completed
Last Updated

September 28, 2020

Status Verified

September 1, 2020

Enrollment Period

9 months

First QC Date

March 8, 2019

Last Update Submit

September 24, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fractional synthetic rate of myofibrillar proteins

    Myofibrillar protein synthesis rates will be assessed during the postabsorptive period for 3 hr and during the 5 hr after the ingestion of the experimental interventions. This will allow us to assess the change from the postabsorptive to the postprandial period.

    Postabsorptive for 3 hours, postprandial for 5 hours.

Secondary Outcomes (2)

  • Phosphorylation of muscle anabolic signaling

    Baseline and at 2 and 5 hours after protein ingestion

  • Exogenous rate of leucine appearance

    5 hour postprandial phase

Study Arms (2)

Salmon

ACTIVE COMPARATOR

After resistance exercise, participants will ingest 3.5 oz of salmon fillet (21g protein, 24g fat) cooked sous-vide.

Behavioral: Resistance exerciseOther: Salmon

Isolated mixture

EXPERIMENTAL

After resistance exercise, participants will ingest an isolated amino acid and fatty acid mixture matched to the amino acid and fatty acid content of 3.5 oz salmon fillet.

Behavioral: Resistance exerciseDietary Supplement: Isolated amino acids and fatty acids

Interventions

Participants will perform leg press and leg extension immediately prior to ingestion of salmon or isolated mixture

Isolated mixtureSalmon
SalmonOTHER

Participants will ingest salmon immediately after resistance exercise

Salmon

Participants will ingest a mixture of isolated amino acids and fatty acids immediately after resistance exercise

Isolated mixture

Eligibility Criteria

Age20 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 20-35 years
  • Recreationally-active adults: ≥ 30 min of physical activity at moderate intensity ≥ 3 times per week
  • English fluency

You may not qualify if:

  • Smoking
  • Known allergies to fish consumption
  • Vegans
  • Diagnosed GI tract diseases
  • Arthritic conditions
  • A history of neuromuscular problems
  • Diagnosed cognitive impairments
  • Recent (1 year) participation in amino acid tracer studies
  • Predisposition to hypertrophic scarring or keloid formation
  • Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
  • High blood pressure (Systolic \> 140 mm HG; Diastolic \> 90 mm HG)
  • Alcohol consumption \>10 drinks per week
  • Metabolic disorders (e.g., Metabolic Syndrome, diabetes, thyroid diseases)
  • Consumption of thyroid, androgenic or other medications known to affect endocrine function
  • Consumption of ergogenic-leves of dietary supplements that may affect muscle mass (e.g., creatine, HMB), insulin-like substances, or anabolic/catabolic pro-hormones (e.g., DHEA) within 6 weeks prior to participation
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Freer Hall

Urbana, Illinois, 61801, United States

Location

Related Publications (1)

  • Paulussen KJ, Barnes TM, Askow AT, Salvador AF, McKenna CF, Scaroni SE, Fliflet A, Ulanov AV, Li Z, West DW, Bauer LL, Paluska SA, Dilger RN, Moore DR, Boppart MD, Burd NA. Underpinning the Food Matrix Regulation of Postexercise Myofibrillar Protein Synthesis by Comparing Salmon Ingestion With the Sum of Its Isolated Nutrients in Healthy Young Adults. J Nutr. 2023 May;153(5):1359-1372. doi: 10.1016/j.tjnut.2023.02.037. Epub 2023 Mar 2.

MeSH Terms

Conditions

Hypertrophy

Interventions

Resistance TrainingFatty Acids

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaLipids

Study Officials

  • Nicholas A Burd, PhD

    University of Illinois at Urbana-Champaign

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 8, 2019

First Posted

March 11, 2019

Study Start

March 1, 2019

Primary Completion

November 22, 2019

Study Completion

November 22, 2019

Last Updated

September 28, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations